Nuclear Respiratory Factor-1 (NRF-1), A Versatile Therapeutic Target: Influence of Plant Metabolites
Click to view Pdf

Keywords

Nuclear respiratory factor-1
Plant metabolites
Mitochondria
Oxidative stress
Diseases

How to Cite

Nuclear Respiratory Factor-1 (NRF-1), A Versatile Therapeutic Target: Influence of Plant Metabolites. (2020). African Journal of Biomedical Research, 23(1), 1-8. https://doi.org/10.4314/

Abstract

Nuclear-encoded transcriptional regulatory proteins called transcription factors can potentially influence mitochondrial gene 
expression directly or indirectly. Mitochondria contain their own genome, which encodes 13 of the ∼100 proteins that constitute 
the enzyme complexes of the respiratory chain. Mitochondria are the fuel stations of all eukaryotic cells and functions as central 
component of mammalian cellular survival through production of ATP and re-oxidized NAD. Nuclear respiratory factor-1 (NRF1) coordinates the expression of nuclear and mitochondrial genes for mitochondrial biogenesis. It increases mitochondrial 
respiratory capacity and induces expression of a subset of genes governing mitochondrial activity. It has a major function in 
cellular adaptation to energy demands by translating physiological signals into an enhanced capacity for energy production. 
Oxidative stress has been implicated in the pathogenesis of many diseases such as diabetes, cardiovascular disease, cancer and 
neurodegenerative diseases. NRF proteins are also essential in the upregulation of antioxidant and xenobiotic-metabolizing 
enzymes during oxidative stress. NRF-1 plays a role in mediating activation of oxidative stress response genes through 
antioxidant response element and hence, confirms its potential roles in chronic diseases. This review has clearly revealed the 
versatility of NRF- 1 as a therapeutic target and showed that plants could exhibit their fight against diseases through activation 
of NRF-1.

Click to view Pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.